2ⁿᵈ Edition of the Cancer R&D World Conference 2026
Scientific Sessions
Immuno Oncology and Cell Based Therapies
Immuno-oncology is a new frontier in cancer therapy, utilizing the body's own immune system to recognize and kill tumor cells. Breakthroughs in checkpoint inhibitors, cancer vaccines, and adoptive cell therapies such as CAR-T and TCR-engineered cells have revolutionized treatment modalities across a wide range of malignancies. These newer innovations not only improve survival in patients but also generate more durable responses. Advances in cellular engineering, gene editing, and combination immunotherapies continue to expand the boundaries of personalized cancer care.
New developments in immune-based treatments and their translation into clinical practice will be presented at the Cancer Research and Development Conference 2026. Discussions will include mechanisms of immune resistance, emerging biomarkers for the selection of patients, and strategies to improve the safety and efficacy of cell therapies. Join us in this session as we cover how immuno-oncology shapes the next generation of transformative cancer treatments through precision, innovation, and immune empowerment.
Related Sessions
We, the Precision Global Conferences, welcome all the students, scholars, researchers, and delegates across the globe to patronize their presence at the& ...
Read More>>
Organizer
